TY - JOUR
T1 - Effectiveness of smoking-cessation interventions for urban hospital patients
T2 - study protocol for a randomized controlled trial
AU - Grossman, Ellie
AU - Shelley, Donna
AU - Braithwaite, R. S.
AU - Lobach, Iryna
AU - Goffin, Ana
AU - Rogers, Erin
AU - Sherman, Scott
N1 - Copyright:
Copyright 2013 Elsevier B.V., All rights reserved.
PY - 2012/8/1
Y1 - 2012/8/1
N2 - Background: Hospitalization may be a particularly important time to promote smoking cessation, especially in the immediate post-discharge period. However, there are few studies to date that shed light on the most effective or cost-effective methods to provide post-discharge cessation treatment, especially among low-income populations and those with a heavy burden of mental illness and substance use disorders.Methods/design: This randomized trial will compare the effectiveness and cost-effectiveness of two approaches to smoking cessation treatment among patients discharged from two urban public hospitals in New York City. During hospitalization, staff will be prompted to ask about smoking and to offer nicotine replacement therapy (NRT) on admission and at discharge. Subjects will be randomized on discharge to one of two arms: one arm will be proactive multi-session telephone counseling with motivational enhancement delivered by study staff, and the other will be a faxed or online referral to the New York State Quitline. The primary outcome is 30-day point-prevalence abstinence from smoking at 6-month follow-up post-discharge. We will also examine cost-effectiveness from a societal and a payer perspective, as well as explore subgroup analyses related to patient location of hospitalization, race/ethnicity, immigrant status, and inpatient diagnosis.Discussion: This study will explore issues of implementation feasibility in a post-hospitalization patient population, as well as add information about the effectiveness and cost-effectiveness of different strategies for designing smoking cessation programs for hospitalized patients.Trial registration: Clinicaltrials.gov ID# NCT01363245.
AB - Background: Hospitalization may be a particularly important time to promote smoking cessation, especially in the immediate post-discharge period. However, there are few studies to date that shed light on the most effective or cost-effective methods to provide post-discharge cessation treatment, especially among low-income populations and those with a heavy burden of mental illness and substance use disorders.Methods/design: This randomized trial will compare the effectiveness and cost-effectiveness of two approaches to smoking cessation treatment among patients discharged from two urban public hospitals in New York City. During hospitalization, staff will be prompted to ask about smoking and to offer nicotine replacement therapy (NRT) on admission and at discharge. Subjects will be randomized on discharge to one of two arms: one arm will be proactive multi-session telephone counseling with motivational enhancement delivered by study staff, and the other will be a faxed or online referral to the New York State Quitline. The primary outcome is 30-day point-prevalence abstinence from smoking at 6-month follow-up post-discharge. We will also examine cost-effectiveness from a societal and a payer perspective, as well as explore subgroup analyses related to patient location of hospitalization, race/ethnicity, immigrant status, and inpatient diagnosis.Discussion: This study will explore issues of implementation feasibility in a post-hospitalization patient population, as well as add information about the effectiveness and cost-effectiveness of different strategies for designing smoking cessation programs for hospitalized patients.Trial registration: Clinicaltrials.gov ID# NCT01363245.
KW - Hospital
KW - Randomized trial
KW - Smoking cessation
KW - Telephone counseling
KW - Underserved population
UR - http://www.scopus.com/inward/record.url?scp=84864402694&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84864402694&partnerID=8YFLogxK
U2 - 10.1186/1745-6215-13-126
DO - 10.1186/1745-6215-13-126
M3 - Article
C2 - 22852878
AN - SCOPUS:84864402694
SN - 1745-6215
VL - 13
JO - Trials
JF - Trials
M1 - 126
ER -